Cargando…
Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin
Durable psoriasis improvement has been reported in a subset of psoriasis patients after treatment withdrawal of biologics blocking IL-23/Type 17 T-cell (T17) autoimmune axis. However, it is not well understood if systemic blockade of the IL-23/T17 axis promotes immune tolerance in psoriasis skin. Th...
Autores principales: | Kim, Jaehwan, Lee, Jongmi, Li, Xuan, Kunjravia, Norma, Rambhia, Darshna, Cueto, Inna, Kim, Katherine, Chaparala, Vasuma, Ko, Younhee, Garcet, Sandra, Zhou, Wei, Cao, Junyue, Krueger, James G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536146/ https://www.ncbi.nlm.nih.gov/pubmed/37781383 http://dx.doi.org/10.3389/fimmu.2023.1250504 |
Ejemplares similares
-
The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
por: Kim, Jaehwan, et al.
Publicado: (2022) -
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
por: Tollenaere, M.A.X., et al.
Publicado: (2021) -
Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis
por: Jabbari, Ali, et al.
Publicado: (2013) -
Cutaneous Expression of A Disintegrin-like and Metalloprotease domain containing Thrombospondin Type 1 motif-like 5 (ADAMTSL5) in Psoriasis goes beyond Melanocytes
por: Bonifacio, Kathleen M, et al.
Publicado: (2016) -
The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)